Kevin J. Oberlander

The board meeting focused on several key items, including license transfer requests, the review of 2026-2027 fiscal year meeting dates, and updates on prescription protocol immunizations. Discussion topics included a recap of the NABP Annual Meeting, an inspection cycle update, District V meeting details, and potential executive session discussions regarding 340B lawsuits. Financial matters included budget reviews, the Executive Director's contract, the approval of executive director actions, and the appointment of board members to manage expense reviews and committee audits. The meeting also included an extensive examination schedule for candidates, final exam scoring, and other administrative business.

The meeting included several key agenda items such as granting a foreign pharmacy internship license, reviewing and approving pharmacy remodel plans for CVS and Keycare Pharmacy, and discussing a central fill service request. Modifications to a pharmacist's order regarding drug access were addressed, and a signed stipulation for another pharmacist was approved. The Board also authorized telepharmacy operations for a specific location, approved relocation plans for another pharmacy, provided financial support for a technician poster presentation, and allocated funding to develop educational resources following new legislation. Additionally, the Board reviewed inspection cycles, discussed upcoming exam preparations and organizational meetings, and addressed legal and financial reporting matters.

The multi-day meeting included the review and approval of the agenda and previous meeting minutes. Key discussions centered on integrating Pharmacy Technicians into the Community Health Worker (CHW) model, exploring models of Pharmacy Technician Education, and addressing workforce recruitment challenges. The Board reviewed rules revisions for Chapter 61 of the ND Administrative Code and discussed the 2026 inspection cycle focus areas, which include Policies and Procedures Manual Standards, DSCSA, Quality Assurance, and Enhanced Patient Care Services. The Board expressed support for legislation allowing pharmacists to practice to the fullest extent of their training during the special 2026 Legislative Session. An intern license was granted to a Foreign Pharmacist contingent upon obtaining a social security number. Discussions during the Profession of Pharmacy Dinner covered legislative funding factors, rural health grants, and advancing the scope of pharmacy practice. Administrative actions included the approval of paid invoices, bank statements, financial reports, and authorization of the Executive Director's legal actions.

The meeting addressed several operational and regulatory items. Key discussions included granting an exception for Technician Rodney Yellow Bird to work alone in Telepharmacy operations, approving an Intern License for Essam Abdelmonem following completion of the Foreign Pharmacy Graduate Equivalency Examination Certification process, and approving the relocation plans for the Mountrail County Medical Center Pharmacy, contingent on future approval for hazardous drug compounding areas. The Board also approved a Stipulation and Settlement Agreement for Valerie Salvaggio and authorized additional space for White Drug #46. Discussions covered legislative updates, positive ID requirements concerning digital IDs, ongoing 340B lawsuits, and the review and approval of the 2024-2025 audit report. The Board also reviewed and approved year-to-date financials and all legal actions taken by the Executive Director.

The North Dakota State Board of Pharmacy meeting included discussions on various topics. The board reviewed relocation plans for Rockview Pharmacy and Mountrail County Medical Center Pharmacy. The board discussed HB1473 lawsuits, board prescriptive protocol, interim legislative updates, and pharmacy technician CE audit. The board also discussed the implications of changes to ACIP recommendations for the Board's vaccination protocol. The board reviewed a request from Sanford South University Fargo regarding their Class B license and filling prescriptions for Urgent Care Clinic patients. The board also discussed universal MPJE and complaints about compounding pharmacies in California.